Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
06/2005
06/22/2005EP1007533B1 Bioconjugates and delivery of bioactive agents
06/22/2005CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury
06/22/2005CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
06/16/2005WO2005053743A1 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
06/16/2005WO2005053682A2 Use of beta-lapachone for protecting against radiation injury
06/16/2005WO2005037928A3 Compounds for dual photodiagnosis and therapy
06/16/2005WO2005017522B1 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy
06/16/2005WO2004084817A3 Siderophore conjugates of photoactive dyes for photodynamic therapy
06/16/2005US20050130952 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
06/16/2005US20050130950 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
06/16/2005US20050130324 Metal nanoshells for biosensing applications
06/16/2005US20050129775 Ferromagnetic particles and methods
06/16/2005US20050129689 Method for treatment of tumors using photodynamic therapy
06/16/2005US20050129680 Antimicrobial activity of antibodies
06/16/2005DE10350248A1 Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik Thermosensitive biocompatible polymer support with variable physical structure for therapy, diagnostics and analytics
06/16/2005CA2546445A1 Use of beta-lapachone for protecting against radiation injury
06/15/2005EP1539222A1 Treatment for eye disorder
06/15/2005EP0967912A4 Chemiluminescent sources for photodynamic therapy and photomedicine
06/15/2005CN1627961A Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues
06/15/2005CN1205999C Liposone composition and method for administration of a radiosensitizer
06/14/2005US6906048 N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity
06/14/2005US6905671 Using isotope of 5-aminolevulinic acid
06/09/2005WO2005051305A2 Enhanced drug delivery
06/09/2005WO2005023096A3 Methods and compositions for ultrasound imaging of apoptosis
06/09/2005US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations
06/09/2005US20050123482 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue
06/09/2005CA2540621A1 Enhanced drug delivery
06/09/2005CA2489673A1 Shape-adaptable and spectral-selective distributed light sources using passive host medium
06/08/2005EP1537867A1 Method of photodynamic diagnosis for vascular diseases
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/02/2005WO2005049008A1 Combinational radiotherapy and chemotherapy compositions and methods
06/02/2005WO2005048944A2 Activatable photodynamic therapy agents
06/02/2005WO2005030253A9 Photocleavable dna transfer agent
06/02/2005WO2004066947B1 Hyperthermia oncolysis co-therapy
06/02/2005US20050118135 System and methods for inducing ischemia in cells
06/02/2005US20050118102 Superparamagnetic nanoparticles with attached, specific targeting moiety; providing in vivo heating
06/02/2005DE19720682B4 Antithrombogenes Material und Verfahren zu dessen Herstellung An antithrombogenic material and process for its preparation
06/02/2005CA2542351A1 Combinational radiotherapy and chemotherapy compositions and methods
06/01/2005EP1534839A1 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression
06/01/2005EP1534702A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
06/01/2005EP1534347A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
06/01/2005EP1534346A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
05/2005
05/31/2005US6900239 Anticancer agents; synergistic mixture
05/31/2005US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/31/2005US6899723 Transcutaneous photodynamic treatment of targeted cells
05/26/2005WO2005046686A1 Methods and compositions using thalidomide for the treatment and management of cancers and other diseases
05/26/2005WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
05/26/2005US20050113697 Method of imaging lymphatic system using nanocapsule compositions
05/26/2005US20050113288 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/26/2005US20050112661 Methods for delivering nucleic acid molecules into cells and assessment thereof
05/26/2005US20050112131 Methods of adjuvant photodynamic therapy to enhance radiation sensitization
05/26/2005US20050112120 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
05/26/2005US20050112113 Supplying drugs to len of eye; applyin genergy; breaking bonds in lenses fibers
05/26/2005US20050112061 Use of a VEGF antagonist in combination with radiation therapy
05/26/2005US20050112059 Enhancement of radiotherapy by an exogenous cardiac glycoside
05/26/2005US20050112058 Auger effect-based cancer therapy method
05/26/2005US20050112021 Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
05/25/2005EP1532976A2 Compositions comprising organic disulfides, cysteine sulfoxides, sulfones, sulfoximines or other sulfur containing substances and their use in therapy in combination with radiation
05/25/2005EP1531843A1 Method for treating cervical cancer
05/25/2005EP1531823A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
05/25/2005EP1056473B1 Targeted delivery of biologically active media
05/25/2005CN1620314A Gas micro-liposome compound
05/25/2005CN1620289A Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
05/24/2005US6897238 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
05/24/2005US6896659 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
05/19/2005WO2005045008A1 Method for inducing chondrogenesis on mesenchymal stem cells
05/19/2005WO2005044309A1 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/19/2005WO2005044182A2 Compositions of botanical extracts for cancer therapy
05/19/2005WO2004091531A3 Methods and devices for epithelial protection during photodynamic therapy
05/19/2005WO2004012667A8 Photoactivated anti-viral and anti-cancer agent
05/19/2005US20050107471 New esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
05/19/2005US20050107346 Synergistic treatment, better effects on solid tumours; with a mixture of a platinum anticancer agents and a taxane, with ionizing radiation therapy
05/19/2005US20050107329 Liposome compositions of porphyrin photosensitizers
05/19/2005US20050106705 Yeast cultures propagated using alternating electric fields for use in regulation of triglycerides and cholesterol levels in blood
05/19/2005US20050106704 Yeast cultures propagated using alternating electric fields for use in treatment of autoimmune diseases
05/19/2005US20050106174 Methods and compositions for treating hepatitis b
05/19/2005US20050106173 Methods and compositions for treating male sexual dysfunction
05/19/2005US20050106172 Using yeast cells; culturing in presence of alternating current
05/19/2005US20050106171 Using yest cells cultured in alternating currrent
05/19/2005US20050106170 Methods and compositions for treating vascular dementia
05/19/2005US20050106169 Methods and compositions for treating renal failure
05/19/2005US20050106168 with yeast cells cultured in the presence of an alternating electric field with a specific frequency and field strength to lower urinary protein and increase serum protein; dietary supplement or medication
05/19/2005US20050106167 Methods and compositions for treating gastroparesis
05/19/2005US20050106166 Administering yeast cells; reducing concentration of collagen in liver; controlling concentration of globulins; culture in alternating electric field
05/19/2005US20050106153 mixture of immunoadjuvant in neoplasm; applying stresses to destroy neoplastic tissue; administering immunomoderator ; in situ generation of autologous vaccine
05/19/2005US20050106105 Complex of annexin and ultrasonic contrast particles or polymer
05/19/2005CA2586320A1 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/19/2005CA2543923A1 Therapy via targeted delivery of nanoscale particles
05/19/2005CA2538218A1 Compositions of botanical extracts for cancer therapy
05/18/2005EP1530571A1 Nucleic acid damage using riboflavin and light
05/18/2005EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors
05/18/2005EP0662137B1 Gene transcription and ionizing radiation: methods and compositions
05/18/2005CN1617668A Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
05/17/2005US6894161 Methods and compositions for photo-cross linking photoactive compounds to target tissue
05/12/2005WO2005043159A1 Water-soluble compound
05/12/2005WO2005042780A1 Phage antibodies to radiation-inducible neoantigens
05/12/2005WO2005042142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
05/12/2005WO2005041662A1 Method for treating collagenous tissue
05/12/2005US20050101677 Prophylaxis and/or reversing presbyopia by applying localized energy to area to be treated and administering biologically acceptable chemical substance capable of breaking chemical bonds such as disulfide bonds between cortical lens fibers
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 95